(Q43523983)

24 November 2017

title

Resolution of corticosteroid-induced diabetes in allergic bronchopulmonary aspergillosis with omalizumab therapy: a novel approach (English)

1 reference

allergic bronchopulmonary aspergillosis

24 November 2017

main subject

0 references

author name string

Inderpal Randhawa

series ordinal

1

1 reference

24 November 2017

Terry Chin

series ordinal

2

1 reference

24 November 2017

Eliezer Nussbaum

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

24 November 2017

1 reference

24 November 2017

volume

46

1 reference

24 November 2017

issue

5

1 reference

24 November 2017

page(s)

445-447

1 reference

Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Development of immune responses to Aspergillus at an early age in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Allergic bronchopulmonary aspergillosis: staging as an aid to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Retrospective analysis of early steroid-induced adverse reactions in kidney and kidney-pancreas transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Management of cystic fibrosis-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900902849871

10.1080/02770900902849871

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference